HTLV-1 and Co-infections

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Human T lymphotropic virus type 1 (HTLV-1) establishes lifelong T-cell infections, altering host immune responses.
• HTLV-1 is linked to inflammatory conditions, leukemia, and increased all-cause mortality.
• As a blood-borne and sexually transmitted infection, HTLV-1 frequently co-occurs with other pathogens, particularly in tropical regions.

Purpose of the Study:

• To review the impact of HTLV-1 on various co-infections and the reciprocal influence of co-infections on HTLV-1 associated diseases.
• To explore the mechanisms underlying increased susceptibility to infections in people living with HTLV-1 (PLHTLV).
• To highlight the public health implications of HTLV-1 co-infections.

Main Methods:

• Comprehensive literature review of studies investigating HTLV-1 co-infections.
• Analysis of evidence regarding the association of HTLV-1 with bacterial, parasitic, and viral infections.
• Examination of immune alterations in co-infected individuals.

Main Results:

• Increased rates of HTLV-1 infection are observed with blood-borne (HCV, HBV) and sexually transmitted infections (Syphilis, Chlamydia, HPV, HSV).
• Higher prevalence of Mycobacterium tuberculosis, Mycobacterium leprae, opportunistic infections, and crusted scabies in PLHTLV suggests immune impairment.
• HTLV-1 is associated with treatment failure in parasitic infections (Schistosoma mansoni, Strongyloides stercoralis) and increased severity of tuberculosis and potentially leprosy.
• HTLV-1 may negatively impact the clinical course of Hepatitis C.

Conclusions:

• HTLV-1 co-infections contribute to increased mortality through complex immune interactions.
• Further large-scale prospective studies are needed to elucidate the prevalence and impact of these co-infections.
• Increased awareness and prevention strategies for HTLV-1 are essential public health measures.